 |
124 Diseases |  |
24 Trials |
|
24 Trials |  |
2082 News |  |
| «12...14151617181920212223242526» |
- atenolol / Generic mfg., lisinopril / Generic mfg.
Enrollment closed, Trial primary completion date: Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=100, Active, not recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Mar 2017
- lisinopril / Generic mfg.
Trial completion, Trial primary completion date: The VALIDATE-D Study (clinicaltrials.gov) - Feb 2, 2016
P=N/A, N=40, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Mar 2017 Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Dec 2015
- lisinopril / Generic mfg.
Trial primary completion date: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=50, Active, not recruiting, Sponsor: Mayo Clinic
Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Dec 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- | exenatide DUROS subcutaneous delivery system (ITCA 650) / i20 Therap
New P1 trial: Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs (clinicaltrials.gov) - Dec 30, 2015
P1, N=33, Recruiting, Sponsor: Intarcia Therapeutics
- New P1 trial: The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors (clinicaltrials.gov) - Dec 5, 2015
P1, N=20, Recruiting, Sponsor: Memorial Health University Medical Center
- Enrollment open, Trial initiation date, Trial primary completion date, Surgery: Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery (clinicaltrials.gov) - Dec 4, 2015
P4, N=300, Enrolling by invitation, Sponsor: University of Nebraska
Trial primary completion date: Dec 2015 --> Dec 2016 Not yet recruiting --> Enrolling by invitation | Initiation date: Oct 2015 --> Jun 2015 | Trial primary completion date: Jan 2016 --> Apr 2016
- ||||| Tryvio (aprocitentan) / J&J
New P2 trial: Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension (clinicaltrials.gov) - Nov 14, 2015
P2, N=540, Not yet recruiting, Sponsor: Actelion
- lisinopril / Generic mfg.
Enrollment closed: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer (clinicaltrials.gov) - Oct 30, 2015
P=N/A, N=50, Active, not recruiting, Sponsor: Mayo Clinic
Not yet recruiting --> Enrolling by invitation | Initiation date: Oct 2015 --> Jun 2015 | Trial primary completion date: Jan 2016 --> Apr 2016 Recruiting --> Active, not recruiting
- Enrollment change: HYGIA: Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment (clinicaltrials.gov) - Oct 22, 2015
P4, N=18000, Recruiting, Sponsor: University of Vigo
Recruiting --> Active, not recruiting N=15000 --> 18000
- lisinopril / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: PIL-FAST: Paramedic Initiated Lisinopril For Acute Stroke Treatment (clinicaltrials.gov) - Oct 8, 2015
P1, N=14, Completed, Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
N=15000 --> 18000 Recruiting --> Completed | N=60 --> 14 | Trial primary completion date: Sep 2011 --> Dec 2011
- ||| lisinopril / Generic mfg.
Trial completion, Trial completion date: Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease (clinicaltrials.gov) - Oct 8, 2015
P=N/A, N=90, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Completed | N=60 --> 14 | Trial primary completion date: Sep 2011 --> Dec 2011 Recruiting --> Completed | Trial completion date: Mar 2012 --> Dec 2011
- lisinopril / Generic mfg.
Trial completion, Trial primary completion date: ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study (clinicaltrials.gov) - Aug 19, 2015
P4, N=30, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | Trial completion date: Mar 2012 --> Dec 2011 Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Dec 2014
- ||| Herceptin (trastuzumab) / Roche
Enrollment closed, Trial primary completion date, Adverse events: Lisinopril or Coreg CR (clinicaltrials.gov) - Jul 9, 2015
P2, N=468, Active, not recruiting, Sponsor: University of South Florida
Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Dec 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Jul 2017
- hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
Enrollment change: 1HAT: Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril (clinicaltrials.gov) - May 20, 2015
P=N/A, N=2, Completed, Sponsor: Scripps Translational Science Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Jul 2017 N=10 --> 2
- Tekturna (aliskiren) / PDL
Enrollment change: ARID-HF: Aliskiren and Renin Inhibition in Diastolic Heart Failure (clinicaltrials.gov) - May 12, 2015
P=N/A, N=0, Withdrawn, Sponsor: Texas Tech University Health Sciences Center
N=10 --> 2 N=60 --> 0
- | atenolol / Generic mfg., lisinopril / Generic mfg.
New P4 trial: Evaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop Hypertension (clinicaltrials.gov) - May 12, 2015
P4, N=85, Completed, Sponsor: Milton S. Hershey Medical Center
- lisinopril / Generic mfg.
Trial completion: Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (clinicaltrials.gov) - Apr 30, 2015
P1, N=24, Completed, Sponsor: Adil Bharucha
N=60 --> 0 Recruiting --> Completed
- lisinopril / Generic mfg.
Trial primary completion date: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=50, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
- Bystolic (nebivolol) / Menarini, AbbVie
Trial primary completion date: FINE-PATH: Non-invasive Haemodynamic Assessment in Hypertension (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=140, Recruiting, Sponsor: Military Institute of Medicine, Poland
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2015 --> Sep 2015
- hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
New trial: Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension (clinicaltrials.gov) - Apr 9, 2015
P=N/A, N=50, Enrolling by invitation, Sponsor: The University of Texas Health Science Center, Houston
- losartan / Generic mfg., lisinopril / Generic mfg.
Enrollment change: Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria (clinicaltrials.gov) - Apr 7, 2015
P3, N=0, Withdrawn, Sponsor: Mayo Clinic
Trial primary completion date: Mar 2015 --> Sep 2015 N=40 --> 0
- ||||||| Trial completion: HALT Progression of Polycystic Kidney Disease Study B (clinicaltrials.gov) - Mar 10, 2015
P3, N=486, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
N=40 --> 0 Active, not recruiting --> Completed
- | losartan / Generic mfg., lisinopril / Generic mfg.
Trial completion: VA NEPHRON-D: Diabetes iN Nephropathy Study (clinicaltrials.gov) - Mar 3, 2015
P3, N=1448, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Trial completion: HALT Progression of Polycystic Kidney Disease Study A (clinicaltrials.gov) - Feb 27, 2015
P3, N=558, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- lisinopril / Generic mfg.
Trial primary completion date: ACSRD: Renal Denervation in Patients After Acute Coronary Syndrome (clinicaltrials.gov) - Feb 26, 2015
P2, N=80, Recruiting, Sponsor: Meshalkin Research Institute of Pathology of Circulation
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Jun 2015
- | lisinopril / Generic mfg.
New P2 trial: Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis (clinicaltrials.gov) - Feb 24, 2015
P2, N=20, Recruiting, Sponsor: Transparency Life Sciences
- lisinopril / Generic mfg.
New P4 trial: Drug to Prevent Pneumonia in the Tube Fed (clinicaltrials.gov) - Feb 9, 2015
P4, N=93, Terminated, Sponsor: Chinese University of Hong Kong
- lisinopril / Generic mfg.
Trial primary completion date: The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study (clinicaltrials.gov) - Jan 30, 2015
P=N/A, N=30, Recruiting, Sponsor: Brigham and Women's Hospital
Trial primary completion date: Jun 2014 --> Jun 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- ||| hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
Combination therapy: The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients. (clinicaltrials.gov) - Jan 13, 2015
P=N/A, N=529, Completed, Sponsor: AstraZeneca
- ||| Trial initiation date, Trial primary completion date, Surgery: Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery (clinicaltrials.gov) - Dec 5, 2014
P4, N=300, Not yet recruiting, Sponsor: University of Nebraska
Trial primary completion date: Dec 2015 --> Dec 2016 Initiation date: Oct 2012 --> Oct 2015 | Trial primary completion date: Jan 2014 --> Jan 2016
- | candesartan cilexetil / Generic mfg., lisinopril / Generic mfg.
Enrollment open: CALIBREX: CAndesartan vs LIsinopril Effects on the BRain (clinicaltrials.gov) - Nov 11, 2014
P3, N=140, Recruiting, Sponsor: Ihab M. Hajjar
Initiation date: Oct 2012 --> Oct 2015 | Trial primary completion date: Jan 2014 --> Jan 2016 Not yet recruiting --> Recruiting
- Enrollment change: HYGIA: Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment (clinicaltrials.gov) - Oct 15, 2014
P4, N=15000, Recruiting, Sponsor: University of Vigo
Not yet recruiting --> Recruiting N=12000 --> 15000
- | lisinopril / Generic mfg.
Enrollment closed: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (clinicaltrials.gov) - Oct 15, 2014
P2/3, N=120, Active, not recruiting, Sponsor: Cooperative International Neuromuscular Research Group
N=12000 --> 15000 Recruiting --> Active, not recruiting
- || Trial completion, Enrollment change, Trial primary completion date: Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients? (clinicaltrials.gov) - Oct 2, 2014
P3, N=35, Completed, Sponsor: University Hospital, Clermont-Ferrand
Recruiting --> Active, not recruiting Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Dec 2012 --> Jun 2014
- | atenolol / Generic mfg., lisinopril / Generic mfg.
Trial completion: Hypertension in Hemodialysis Patients (Aim 3) (clinicaltrials.gov) - Sep 29, 2014
P3, N=200, Completed, Sponsor: Indiana University
Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Dec 2012 --> Jun 2014 Active, not recruiting --> Completed
- lisinopril / Generic mfg.
Trial primary completion date: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer (clinicaltrials.gov) - Sep 15, 2014
P=N/A, N=50, Recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Dec 2014
- lisinopril / Generic mfg.
New P1 trial: Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (clinicaltrials.gov) - Sep 5, 2014
P1, N=24, Recruiting, Sponsor: Adil Bharucha
- Rybelsus (semaglutide oral) / Novo Nordisk
Trial completion: A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects (clinicaltrials.gov) - Aug 26, 2014
P1, N=52, Completed, Sponsor: Novo Nordisk A/S
Trial primary completion date: Sep 2014 --> Dec 2014 Active, not recruiting --> Completed
- Trial primary completion date: Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors (clinicaltrials.gov) - Jul 23, 2014
P2, N=6, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed Trial primary completion date: Jun 2012 --> Dec 2013
- lisinopril / Generic mfg.
Trial primary completion date: The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study (clinicaltrials.gov) - Jul 15, 2014
P=N/A, N=30, Recruiting, Sponsor: Brigham and Women's Hospital
Trial primary completion date: Jun 2012 --> Dec 2013 Trial primary completion date: Oct 2014 --> Dec 2015
- lisinopril / Generic mfg.
Enrollment open: Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension (clinicaltrials.gov) - Jul 12, 2014
P4, N=33, Recruiting, Sponsor: University Ghent
Trial primary completion date: Oct 2014 --> Dec 2015 Active, not recruiting --> Recruiting
- lisinopril / Generic mfg.
New P4 trial: Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension (clinicaltrials.gov) - Jul 10, 2014
P4, N=33, Active, not recruiting, Sponsor: University Ghent
- | candesartan cilexetil / Generic mfg., lisinopril / Generic mfg.
Trial initiation date: CALIBREX: CAndesartan vs LIsinopril Effects on the BRain (clinicaltrials.gov) - May 5, 2014
P3, N=140, Not yet recruiting, Sponsor: Ihab M. Hajjar
Active, not recruiting --> Recruiting Initiation date: Feb 2014 --> Jul 2014
- Rybelsus (semaglutide oral) / Novo Nordisk
Enrollment closed: A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects (clinicaltrials.gov) - May 5, 2014
P1, N=52, Active, not recruiting, Sponsor: Novo Nordisk A/S
Initiation date: Feb 2014 --> Jul 2014 Recruiting --> Active, not recruiting
- Enrollment change: Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors (clinicaltrials.gov) - Apr 21, 2014
P2, N=6, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Recruiting --> Active, not recruiting N=40 --> 6
- Humira (adalimumab) / AbbVie
Enrollment change: Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial (clinicaltrials.gov) - Apr 9, 2014
P2, N=23, Completed, Sponsor: New York University School of Medicine
N=40 --> 6 N=179 --> 23
- Humira (adalimumab) / AbbVie
Trial completion: Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial (clinicaltrials.gov) - Apr 9, 2014
P2, N=23, Completed, Sponsor: New York University School of Medicine
N=179 --> 23 Active, not recruiting --> Completed
- hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
Trial completion: 1HAT: Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril (clinicaltrials.gov) - Mar 30, 2014
P=N/A, N=10, Completed, Sponsor: Scripps Translational Science Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: HYGIA: Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment (clinicaltrials.gov) - Mar 17, 2014
P4, N=12000, Recruiting, Sponsor: University of Vigo
Active, not recruiting --> Completed N=5000 --> 12000
- Rybelsus (semaglutide oral) / Novo Nordisk
Enrollment open: A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects (clinicaltrials.gov) - Feb 27, 2014
P1, N=52, Recruiting, Sponsor: Novo Nordisk A/S
N=5000 --> 12000 Not yet recruiting --> Recruiting